Greg Pientka
Optometrist · Boynton Beach, FLNPI 1699723452
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.7%), speaking fees and entertainment — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Alcon at 47.5% of the total. Reporting peaked in 2023 at $3,678 and has fallen 87.2% since, to $470 in 2025. Among optometrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $85.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$4K
- Coopervision Inc.$885
- Bausch & Lomb Americas Inc.$857
- Bausch & Lomb, A Division Of Bausch Health US, LLC$599
- Visionary Optics LLC$360
- Johnson & Johnson Vision Care, Inc.$347
- plus $1K from 13 others
What the payments were for
- Speaking & faculty fees$3,00036%
- Food & beverage$4,81758%
- Education$50%
- Gifts$2623%
- Entertainment$2663%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 25 | $3,962 |
| Coopervision Inc. | 20 | $885 |
| Bausch & Lomb Americas Inc. | 14 | $857 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 9 | $599 |
| Visionary Optics LLC | 2 | $360 |
| Johnson & Johnson Vision Care, Inc. | 8 | $347 |
| Optos, Inc. | 4 | $336 |
| Sight Sciences, Inc. | 2 | $252 |
| Tarsus Pharmaceuticals, Inc. | 1 | $150 |
| Sun Pharmaceutical Industries Inc. | 1 | $117 |
| Optovue, Inc. | 2 | $114 |
| LKC Technologies, Inc. | 1 | $99 |
| Oyster Point Pharma, Inc. | 2 | $98 |
| AbbVie | 1 | $68 |
| Shire North American Group Inc | 2 | $32 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Novartis | 1 | $19 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
| Lombart Brothers, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Precision 1$3,103
- DAILIES TOTAL1$2,150
- AIR OPTIX$2,000
- AIR OPTIX for Astigmatism$2,000
- Dailies Aqua Comfort Plus$2,000
- INFUSE$362
- BIOTRUE ONE DAY$337
- ULTRA$331
- MyDay Contact Lens$232
- OCT OPHTHALMOSCOPE$225
- PANORAMIC OPHTHALMOSCOPE$225
- XDEMVY$150
- TEARCARE SYSTEM$137
- Acuvue$121
- BTOD$120
- Precision7$119
- XELPROS$117
- BROMSITE$117
- CEQUA$117
- TearCare$116
How this compares
$8,349 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 38 | $51,344 |
| LumiganBimatoprost | 43 | $22,814 |
| Cyclosporine | 13 | $7,604 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 22 | $4,579 |
| TafluprostTafluprost/Pf | 16 | $4,295 |
| CombiganBrimonidine Tartrate/Timolol | 18 | $3,927 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 13 | $2,816 |
| Loteprednol Etabonate | 16 | $2,313 |
| Travoprost | 23 | $2,191 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 51 | $1,846 |
| Latanoprost | 165 | $1,764 |
| Prednisolone Acetate | 23 | $897 |
| Dorzolamide Hcl | 18 | $357 |
| Timolol Maleate | 28 | $227 |
| Brimonidine Tartrate | 17 | $105 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan | $68 | $78,08599 claims |
| AlconSimbrinza | $3,962 | $4,57922 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $599 | $2,31316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,166 optometrist providers in Florida.
Other optometrist in Boynton Beach
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$553K
- Nora CothranLargo$505K
- Michael SluskyNorth Port$384K
- Katie SpearDefuniak Springs$361K
- Karen HoffmanOrange Park$282K
- Ashley RothMiami Beach$261K
- Jessica SteenDavie$256K
- Mark DunbarMiami$236K
- Robert DavisPembroke Pines$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.